^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    AmpliMark™

    Company:
    Lucence
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    11ms
    Lucence showcases liquid biopsy tech for earlier cancer detection at 2023 ASCO Annual Meeting (Lucence Press Release)
    "Lucence will present promising new data on earlier cancer detection based on AmpliMark, its amplicon-based next generation sequencing technology at the 59th Annual ASCO Meeting in Chicago, June 2-6, 2023."
    Clinical data
    |
    AmpliMark™